103 results
8-K
EX-10.1
1lb xa2a1aqhpaby
19 Sep 22
Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer
8:10am
424B3
cfhh5nld
14 Jan 21
Prospectus supplement
5:11pm
S-4/A
nmwd g6a4qp4u
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm
S-4/A
EX-10.25
gkjhb4y7rf04bdq v9x9
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm
S-4/A
EX-10.24
m7sih165y0k6je bsa
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm
S-4
c48ztmqwgsof5hn7vb
22 Dec 20
Registration of securities issued in business combination transactions
6:24am